Median Technologies SA (ALMDT) - Product Pipeline Analysis, 2024 Update

Median Technologies SA (ALMDT) - Product Pipeline Analysis, 2024 Update


Summary

Median Technologies SA (Median Technologies) is a medical technology company that develops and markets medical imaging solutions. The company's offers eyonis, an artificial intelligence (AI) and machine learning (MI) based CADx (computer-aided diagnosis) software as medical device (SaMD) used for the early detection, screening and treatment of lung and liver cancers. The company also provide iSee Viewer and iSee Portal platform for managing and analyzing medical imaging data. Median Technologies offering services including oncology clinical trials imaging services and core lab imaging services. It serves to biopharma companies, CROs, health professionals and patients. The company operates in the US, China and France. Median Technologies is headquartered in Valbonne, Provence - Alpes- Cote d'Azur, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Median Technologies SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


Median Technologies SA Company Overview
Median Technologies SA Company Snapshot
Median Technologies SA Pipeline Products and Ongoing Clinical Trials Overview
Median Technologies SA – Pipeline Analysis Overview
Median Technologies SA - Key Facts
Median Technologies SA - Major Products and Services
Median Technologies SA Pipeline Products by Development Stage
Median Technologies SA Pipeline Products Overview
eyonis - IPN
eyonis - IPN Product Overview
Eyonis LCS
Eyonis LCS Product Overview
Liver Cancer CADe
Liver Cancer CADe Product Overview
Liver Cancer CADx
Liver Cancer CADx Product Overview
Liver Disease (NAFLD/NASH) De/Dx
Liver Disease (NAFLD/NASH) De/Dx Product Overview
Pheno iDx HCC Recurrence
Pheno iDx HCC Recurrence Product Overview
Pheno iDx Liver
Pheno iDx Liver Product Overview
Pheno iDx NASH
Pheno iDx NASH Product Overview
Median Technologies SA - Key Competitors
Median Technologies SA - Key Employees
Median Technologies SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Median Technologies SA, Recent Developments
May 29, 2024: Median Technologies to Participate in the 2024 ASCO Annual Meeting, May 31 - June 4, 2024, McCormick Place, Chicago, IL, USA
May 21, 2024: Median Technologies, a World Leading Oncology Clinical Trial Imaging Services Provider, Becomes Preferred Vendor to Another Top 3 Pharmaceutical Company
Feb 26, 2024: Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria
Dec 14, 2023: Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine
Nov 30, 2023: Median Technologies to Speak at the IASLC 2023 North America Conference on Lung Cancer (NACLC), Dec. 1-3, Chicago, IL, USA, with Two Presentations
Nov 27, 2023: Median Technologies Selected for Support Under the French Government's ETIncelles Program
Nov 26, 2023: Median Technologies Announces Rebranding of iBiopsy, Changes Name to eyonis
Oct 17, 2023: First Results of Median Technologies’ iBiopsy HCC Detection AI Model Developed on the PHELICAR Clinical Data Registry, to Be Presented at the ESMO Congress (Oct 20-24, 2023, Madrid, Spain)
Oct 16, 2023: Median Technologies’ Global iCRO Team to participate in the 2023 ESMO Congress, Oct 20 – 24, 2023, Madrid, Spain
Feb 27, 2023: Median Technologies announces completion of the Q-Submission phase with the FDA for its iBiopsy lung cancer screening CADe/CADx software as medical device
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Median Technologies SA Pipeline Products and Ongoing Clinical Trials Overview
Median Technologies SA Pipeline Products by Equipment Type
Median Technologies SA Pipeline Products by Indication
Median Technologies SA, Key Facts
Median Technologies SA, Major Products and Services
Median Technologies SA Number of Pipeline Products by Development Stage
Median Technologies SA Pipeline Products Summary by Development Stage
eyonis - IPN - Product Status
eyonis - IPN - Product Description
Eyonis LCS - Product Status
Eyonis LCS - Product Description
Liver Cancer CADe - Product Status
Liver Cancer CADe - Product Description
Liver Cancer CADx - Product Status
Liver Cancer CADx - Product Description
Liver Disease (NAFLD/NASH) De/Dx - Product Status
Liver Disease (NAFLD/NASH) De/Dx - Product Description
Pheno iDx HCC Recurrence - Product Status
Pheno iDx HCC Recurrence - Product Description
Pheno iDx Liver - Product Status
Pheno iDx Liver - Product Description
Pheno iDx NASH - Product Status
Pheno iDx NASH - Product Description
Median Technologies SA, Key Employees
Median Technologies SA, Other Locations
Median Technologies SA, Subsidiaries
Glossary
List of Figures
Median Technologies SA Pipeline Products by Equipment Type
Median Technologies SA Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings